Physician profile
Eric Adrid
NPI 1891880662
$4,074.36
in general payments reported to CMS, 2019-2025
18 companies · $462 in 2025
The $462 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $989 · 2022: $940 · 2023: $1,153 · 2024: $530 · 2025: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,145.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,081.42 | 2021-2024 | Ubrelvy, Vraylar, Qulipta |
| Amgen INC. | $544.70 | 2021-2025 | Otezla, Otezla, Repatha |
| Astrazeneca Pharmaceuticals LP | $496.14 | 2021-2025 | Airsupra, Breztri |
| Pfizer INC. | $255.54 | 2021-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $99.28 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $83.19 | 2023-2024 | Rexulti |
| Astellas Pharma US INC | $78.69 | 2024 | Veozah |
| Merck Sharp & Dohme LLC | $67.64 | 2021-2024 | M-M-R II, Gardasil 9, Capvaxive |
| Novo Nordisk INC | $65.85 | 2022-2024 | Wegovy |
| Exact Sciences Corporation | $56.68 | 2023 | Cologuard Collection Kit |
| Idorsia Pharmaceuticals US INC | $51.16 | 2023-2024 | Quviviq |
| Lilly USA, LLC | $47.14 | 2021-2023 | Zepbound, Mounjaro |
| Medtronic, INC. | $38.11 | 2022-2024 | Intellis Adaptivestim |
| E.R. Squibb & Sons, L.L.C. | $36.83 | 2021 | |
| Organon LLC | $27.36 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $18.31 | 2023 | Krystexxa |
| Eisai INC. | $13.78 | 2021 | |
| Medicure Pharma INC. | $12.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Adrid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.